Clinical trials
Hepatitis B trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
| Completed | 8 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Third Affiliated Hospital, Sun Yat-Sen University | 7 |
| Beijing Ditan Hospital | 3 |
| Eastern Hepatobiliary Surgery Hospital | 2 |
| Hospital Authority, Hong Kong | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Sun Yat-sen University | 2 |
| Air Force Military Medical University, China | 1 |
| Beijing 302 Hospital | 1 |
| Beijing Municipal Administration of Hospitals | 1 |
| Chinese University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B | 29 |
| Hepatitis B, Chronic | 7 |
| Acute-On-Chronic Liver Failure | 5 |
| Liver Cirrhosis | 5 |
| Carcinoma, Hepatocellular | 3 |
| Liver Failure | 2 |
| Esophageal and Gastric Varices | 1 |
| Fibrosis | 1 |
| Hepatitis | 1 |
| Hepatitis C | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.